Abstract:Background: Global ischemia is the resulting effect of a cardiopulmonary arrest (CPA). Presently there is no effective treatment to address neurological deficits in patients who survived a CPA. Granulocyte-colony stimulating factor is a growth factor (G-CSF) with a plethora of beneficial effects, including neuroprotection. Clinical application of human G-CSF (hG-CSF) is limited due to its plasma half-life of 4 h. Therefore, novel approaches need to be investigated that would (1) enable prolonged manifestation of hG-CSF and (2) demonstrate G-CSF efficacy from studying the underlying protective mechanisms of hG-CSF. In our previous work, we used the self-complementary adeno-associated virus (stereotype2: scAAV2) as a vector to transfect the hG-CSF gene into the global ischemic brain of a mouse. As an extension of that work, we now seek to elucidate the protective mechanisms of hG-CSF gene therapy against endoplasmic reticulum induced stress, mitochondrial dynamics and autophagy in global ischemia. Method: A single drop of either AAV-CMV-hG-CSF or AAV-CMV-GFP was dropped into the conjunctival sac of the Swiss Webster mouse's left eye, 30-60 min after bilateral common artery occlusion (BCAO). The efficacy of the expressed hG-CSF gene product was analyzed by monitoring the expression levels of endoplasmic reticulum stress (ER), mitochondrial dynamics and autophagic proteins over 4- and 7-days post-BCAO in vulnerable brain regions including the striatum, overlying cortex (frontal brain regions) and the hippocampus (middle brain regions). Statistical analysis was performed using mostly One-Way Analysis of variance (ANOVA), except for behavioral analysis, which used Repeated Measures Two-Way ANOVA, post hoc analysis was performed using the Tukey test. Results: Several biomarkers that facilitated cellular death, including CHOP and GRP78 (ER stress) DRP1 (mitochondrial dynamics) and Beclin 1, p62 and LC3-ll (autophagy) were significantly downregulated by hG-CSF gene transfer. hG-CSF gene therapy also significantly upregulated antiapoptotic Bcl2 while downregulating pro-apoptotic Bax. The beneficial effects of hG-CSF gene therapy resulted in an overall improvement in functional behavior. Conclusion: Taken together, this study has substantiated the approach of sustaining the protein expression of hG-CSF by eye drop administration of the hG-CSF gene. In addition, the study has validated the efficacy of using hG-CSF gene therapy against endoplasmic reticulum induced stress, mitochondrial dynamics and autophagy in global ischemia.

Neuroprotection through G-CSF: recent advances and future viewpoints

Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection.

G-CSF and neuroprotection: a therapeutic perspective in cerebral ischaemia.

Neuroprotection of G-CSF in cerebral ischemia.

Advances in Granulocyte Colony-Stimulating Factor for Cerebral Infarction Treatment

Neuroprotective effect of granulocyte colony-stimulating factor and clinical research progress

The Protective and Reparative Role of Colony-Stimulating Factors in the Brain with Cerebral Ischemia/Reperfusion Injury

Granulocyte colony-stimulating factor effects on neurological and motor function in animals with spinal cord injury: a systematic review and meta-analysis

Effects of Granulocyte Colony-Stimulating Factor on the Proliferation and Cell-Fate Specification of Neural Stem Cells

Neuroplastic and Pro-cognitive Effects of Granulocyte Colony Stimulating Factor in Healthy Adults: A Pilot Study

The Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity

Neuronal protective effect of granulocyte-colony stimulating factor and its related mechanism in acute spinal cord injury

Granulocyte colony-stimulating factor improves neuron survival in experimental spinal cord injury by regulating nucleophosmin-1 expression

Old drug, new use: Recent advances for G-CSF

Granulocyte-colony stimulating factor ameliorates periventricular white matter damage subject to hypoxia via influencing on activation of microglia

Granulocyte-colony Stimulating Factor in Combination with Stem Cell Factor Confers Greater Neuroprotection after Hypoxic–Ischemic Brain Damage in the Neonatal Rats than a Solitary Treatment

The Reversible Effects of Glial Cell Line-Derived Neurotrophic Factor (GDNF) in the Human Brain

Protective Effect of Granulocyte Colony-Stimulating Factor on Intracerebral Hemorrhage in Rat.

Granolocyte-macrophage Clony-Stimulating Factor and Neuroprotection

Cerebral ischemia induces astrocytes to express granulocyte colony stimulating factor and glial cell fine-derived neurotrophic factor

Granulocyte-colony stimulating factor gene therapy as a novel therapeutics for stroke in a mouse model